Please check your internet connection and try again.
# Forcef (Cephradine)
## Overview
Cephradine is a first-generation cephalosporin antibiotic. It acts by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs). It is active against many Gram-positive cocci and some Gram-negative bacteria (e.g., *E. coli, P. mirabilis, K. pneumoniae*).
## Primary Indications
* Respiratory tract infections
* Skin and soft tissue infections
* Urinary tract infections (UTIs)
* Otitis media
* Bone infections (refer to specific guidelines due to bioavailability)
## Adult Dosing
* **Mild to moderate infections:** 250 mg to 500 mg orally every 6 hours.
* **Severe or deep-seated infections:** Up to 1 g orally every 6 hours.
* **Maximum daily dose:** 4 g daily.
* *Note: Dosing frequency and duration depend on local antimicrobial stewardship protocols.*
## Pediatric Dosing
* **General infections:** 25 mg to 50 mg/kg/day orally in divided doses every 6 or 12 hours.
* **Otitis media:** 75 mg to 100 mg/kg/day orally in divided doses every 6 or 12 hours.
* **Maximum daily dose:** Not to exceed adult dosage limits.
## Dose Adjustments
* **Renal Impairment:** Requires dose reduction or longer interval based on creatinine clearance (CrCl).
* CrCl 20–50 mL/min: Reduce dose by 50% or increase interval.
* CrCl <20 mL/min: Not recommended or requires aggressive dose adjustment/expert pharmacist consultation.
* **Hepatic Impairment:** No specific adjustment necessary, but use with caution.
## Contraindications
* Known hypersensitivity to cephradine or any cephalosporin class antibiotic.
* History of severe allergic reaction (anaphylaxis) to penicillins (due to potential cross-reactivity).
## Adverse Effects
* **Common:** Nausea, vomiting, diarrhea, abdominal pain.
* **Serious:** *Clostridioides difficile*-associated diarrhea (CDAD), hypersensitivity reactions (rash, urticaria, anaphylaxis), superinfection, and rarely, elevated liver enzymes or transient neutropenia.
## Key Drug Interactions
* **Probenecid:** Increases serum concentrations of cephradine by decreasing renal tubular secretion.
* **Anticoagulants:** May increase the risk of bleeding (monitor INR if on warfarin/Vitamin K antagonists).
* **Aminoglycosides:** Potential additive nephrotoxicity; monitor renal function if used concomitantly.
## Monitoring
* Monitor for signs of hypersensitivity (rash, dyspnea).
* Assess stool frequency/consistency to monitor for *C. difficile* colitis.
* Monitor renal function in patients on long-term therapy or with pre-existing renal impairment.
## Clinical Pearls
* **Bioavailability:** Cephradine is well-absorbed orally. Food does not significantly affect absorption.
* **Cross-Reactivity:** Use extreme caution in patients with a history of severe Type I hypersensitivity (anaphylaxis) to penicillins.
* **Suspension:** Once reconstituted, oral suspensions should be stored in a refrigerator unless specified otherwise by the manufacturer; discard unused portions after 14 days.
* **Stewardship:** Reserve for appropriate indications to minimize the development of antibiotic resistance; avoid broad-spectrum use for minor self-limiting infections.
***
**Educational Disclaimer:** This information is for educational purposes only. Clinical practices, dosing guidelines, and resistance patterns vary by institution and region. Always consult your current facility’s antimicrobial stewardship program, local clinical guidelines, and the manufacturer’s official package insert before prescribing or administering medication.
